Multigene assays for late recurrence of breast cancer

Affiliations

¹ Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. Electronic address: michail.ignatiadis@bordet.be.

Comment

Michail Ignatiadis. Lancet Oncol. 2013 Oct.

. 2013 Oct;14(11):1029-1030.

doi: 10.1016/S1470-2045(13)70437-6. Epub 2013 Sep 12.

¹ Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. Electronic address: michail.ignatiadis@bordet.be.

No abstract available

Comment on

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Sgroi DC, Sestak I, Cuzick J, Zhang Y, Schnabel CA, Schroeder B, Erlander MG, Dunbier A, Sidhu K, Lopez-Knowles E, Goss PE, Dowsett M. Sgroi DC, et al. Lancet Oncol. 2013 Oct;14(11):1067-1076. doi: 10.1016/S1470-2045(13)70387-5. Epub 2013 Sep 12. Lancet Oncol. 2013. PMID: 24035531 Free PMC article. Clinical Trial.